Top ▲

Plasmodium falciparum 2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase

Click here for help

Target not currently curated in GtoImmuPdb

Malaria Pharmacology Ligand  Target has curated data in GtoMPdb

Target id: 3064

Nomenclature: Plasmodium falciparum 2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase

Abbreviated Name: PfIspD

Family: Isoprenoid biosynthesis enzymes

Gene and Protein Information Click here for help
Species TM AA Chromosomal Location Gene Symbol Gene Name Reference
Plasmodium falciparum 3D7 - 734 IspD 2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase, putative
Previous and Unofficial Names Click here for help
IspD | Pf3D7_01_v3:289,849..292,802(+) | PFA0340w
Database Links Click here for help
Alphafold
PlasmoDB
UniProtKB

Download all structure-activity data for this target as a CSV file go icon to follow link

Inhibitors
Key to terms and symbols View all chemical structures Click column headers to sort
Ligand Sp. Action Value Parameter Reference
MMV008138 Small molecule or natural product Guide to Malaria Pharmacology Ligand Pf Inhibition 8.1 pIC50 2
pIC50 8.1 (IC50 7x10-9 M) [2]
Description: Enzymatic activity measured using a pyrophosphate release assay
Whole Organism Assay Data Linked to This Target
Key to terms and symbols Click column headers to sort
Ligand Sp. Assay description Type Action Value Parameter Reference
MMV008138 Small molecule or natural product Guide to Malaria Pharmacology Ligand PfW2 Parasite growth inhibition assay - - 7.0 pEC50 2
pEC50 7.0 (EC50 1.1x10-7 M) [2]
Lifecycle stages: Plasmodium asexual blood stage (erythrocytic merozoite, trophozoite, erythrocytic schizont)
MMV008138 Small molecule or natural product Guide to Malaria Pharmacology Ligand PfDd2 Parasite growth inhibition assay - - 6.6 pIC50 3
pIC50 6.6 (IC50 2.5x10-7 M) SYBR green assay [3]
Lifecycle stages: Plasmodium asexual blood stage (erythrocytic merozoite, trophozoite, erythrocytic schizont)
Malaria Pharmacology Comments
The non-mevalonate (MEP) pathway of isoprenoid precursor biosynthesis is utilized by bacteria, plants and apicomplexan protozoa but is not present in mammals (complete pathway for P. falciparum is available at www.wikipathways.org). Enzymes of this pathway represent promising therapeutic targets for antimalarial drug development because the pathway is present in the Plasmodium parasite but not in the human host [1].
2-C-methyl-D-erythritol 4-phosphate cytidyltransferase (PfIspD) is the third enzyme in the pathway, following PfDXR.

References

Show »

1. Imlay LS, Armstrong CM, Masters MC, Li T, Price KE, Edwards RL, Mann KM, Li LX, Stallings CL, Berry NG et al.. (2015) Plasmodium IspD (2-C-Methyl-D-erythritol 4-Phosphate Cytidyltransferase), an Essential and Druggable Antimalarial Target. ACS Infect Dis, 1 (4): 157-167. [PMID:26783558]

2. Wu W, Herrera Z, Ebert D, Baska K, Cho SH, DeRisi JL, Yeh E. (2015) A chemical rescue screen identifies a Plasmodium falciparum apicoplast inhibitor targeting MEP isoprenoid precursor biosynthesis. Antimicrob Agents Chemother, 59 (1): 356-64. [PMID:25367906]

3. Yao ZK, Krai PM, Merino EF, Simpson ME, Slebodnick C, Cassera MB, Carlier PR. (2015) Determination of the active stereoisomer of the MEP pathway-targeting antimalarial agent MMV008138, and initial structure-activity studies. Bioorg Med Chem Lett, 25 (7): 1515-9. [PMID:25754494]

How to cite this page

Isoprenoid biosynthesis enzymes : Plasmodium falciparum 2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase. Last modified on 11/10/2021. Accessed on 19/04/2024. IUPHAR/BPS Guide to PHARMACOLOGY, https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=3064.